{"id":49250,"date":"2022-10-06T15:01:53","date_gmt":"2022-10-06T13:01:53","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/owlet-announces-fda-510k-submission-for-prescription-pediatric-monitor\/"},"modified":"2022-10-06T15:01:53","modified_gmt":"2022-10-06T13:01:53","slug":"owlet-announces-fda-510k-submission-for-prescription-pediatric-monitor","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/owlet-announces-fda-510k-submission-for-prescription-pediatric-monitor\/","title":{"rendered":"Owlet Announces FDA 510(k) Submission for Prescription Pediatric Monitor"},"content":{"rendered":"
\n

\nThe Company filed a 510(k) premarket notification for its prescription-only medical device to be used in-home for babies under the supervision of a physician<\/i>\n<\/p>\n

LEHI, Utah–(BUSINESS WIRE)–Owlet, Inc. (NYSE: OWLT) (the \u201cCompany\u201d) announces that it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administration (\u201cFDA\u201d) for a new prescription monitoring device for infants. The Company\u2019s device, which uses pulse oximetry technology, is intended to be prescribed by physicians for assisting with the in-home monitoring of babies under a physician\u2019s care. The device provides alerts to parents when their baby\u2019s heart rate or oxygen saturation level (SpO2<\/sub>) does not fall within prescribed ranges.\n<\/p>\n

\n\u201cAs noted in our recent earnings release, this is a major milestone for Owlet as we work toward our mission, representing several years of work, including clinical and safety studies,\u201d said Kurt Workman, Owlet President, Chief Executive Officer and Co-Founder. \u201cThis device will help the most vulnerable of babies, and we are optimistic about and excited for the opportunity ahead as we develop and expand our core technologies to include medical devices. I\u2019m grateful to our team who has worked tirelessly on this initiative, and we look forward to working through the FDA review process.\u201d\n<\/p>\n

\nAbout Owlet, Inc.
\n
<\/b>Owlet was founded by a team of parents in 2012. Owlet\u2019s mission is to empower parents with the right information at the right time, to give them more peace of mind and help them find more joy in the journey of parenting. Owlet\u2019s digital parenting platform aims to give parents real-time data and insights to help parents feel more calm and confident. Owlet believes that every parent deserves peace of mind and the opportunity to feel their well-rested best. To learn more, visit www.owletcare.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestors
\n
Mike Cavanaugh
\n
Westwicke\/ICR
\n
Phone: +1.617.877.9641
\n
mike.cavanaugh@westwicke.com <\/a>\n<\/p>\n

\nMedia
\n
Jane Putnam
\n
Owlet, Inc.
\n
Phone: +1.801.647.0025
\n
jputnam@owletcare.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

The Company filed a 510(k) premarket notification for its prescription-only medical device to be used in-home for babies under the supervision of a physician LEHI, Utah–(BUSINESS WIRE)–Owlet, Inc. (NYSE: OWLT) (the \u201cCompany\u201d) announces that it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administration (\u201cFDA\u201d) for a new prescription monitoring device … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49250","6":"format-standard","7":"category-industry"},"yoast_head":"\nOwlet Announces FDA 510(k) Submission for Prescription Pediatric Monitor - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/owlet-announces-fda-510k-submission-for-prescription-pediatric-monitor\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Owlet Announces FDA 510(k) Submission for Prescription Pediatric Monitor - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"The Company filed a 510(k) premarket notification for its prescription-only medical device to be used in-home for babies under the supervision of a physician LEHI, Utah–(BUSINESS WIRE)–Owlet, Inc. (NYSE: OWLT) (the \u201cCompany\u201d) announces that it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administration (\u201cFDA\u201d) for a new prescription monitoring device ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/owlet-announces-fda-510k-submission-for-prescription-pediatric-monitor\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-06T13:01:53+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/owlet-announces-fda-510k-submission-for-prescription-pediatric-monitor\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/owlet-announces-fda-510k-submission-for-prescription-pediatric-monitor\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Owlet Announces FDA 510(k) Submission for Prescription Pediatric Monitor\",\"datePublished\":\"2022-10-06T13:01:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/owlet-announces-fda-510k-submission-for-prescription-pediatric-monitor\\\/\"},\"wordCount\":327,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/owlet-announces-fda-510k-submission-for-prescription-pediatric-monitor\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/owlet-announces-fda-510k-submission-for-prescription-pediatric-monitor\\\/\",\"name\":\"Owlet Announces FDA 510(k) Submission for Prescription Pediatric Monitor - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2022-10-06T13:01:53+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/owlet-announces-fda-510k-submission-for-prescription-pediatric-monitor\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/owlet-announces-fda-510k-submission-for-prescription-pediatric-monitor\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/owlet-announces-fda-510k-submission-for-prescription-pediatric-monitor\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Owlet Announces FDA 510(k) Submission for Prescription Pediatric Monitor\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Owlet Announces FDA 510(k) Submission for Prescription Pediatric Monitor - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/owlet-announces-fda-510k-submission-for-prescription-pediatric-monitor\/","og_locale":"en_US","og_type":"article","og_title":"Owlet Announces FDA 510(k) Submission for Prescription Pediatric Monitor - Pharma Trend","og_description":"The Company filed a 510(k) premarket notification for its prescription-only medical device to be used in-home for babies under the supervision of a physician LEHI, Utah–(BUSINESS WIRE)–Owlet, Inc. (NYSE: OWLT) (the \u201cCompany\u201d) announces that it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administration (\u201cFDA\u201d) for a new prescription monitoring device ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/owlet-announces-fda-510k-submission-for-prescription-pediatric-monitor\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-06T13:01:53+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/owlet-announces-fda-510k-submission-for-prescription-pediatric-monitor\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/owlet-announces-fda-510k-submission-for-prescription-pediatric-monitor\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Owlet Announces FDA 510(k) Submission for Prescription Pediatric Monitor","datePublished":"2022-10-06T13:01:53+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/owlet-announces-fda-510k-submission-for-prescription-pediatric-monitor\/"},"wordCount":327,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/owlet-announces-fda-510k-submission-for-prescription-pediatric-monitor\/","url":"https:\/\/pharma-trend.com\/en\/owlet-announces-fda-510k-submission-for-prescription-pediatric-monitor\/","name":"Owlet Announces FDA 510(k) Submission for Prescription Pediatric Monitor - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2022-10-06T13:01:53+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/owlet-announces-fda-510k-submission-for-prescription-pediatric-monitor\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/owlet-announces-fda-510k-submission-for-prescription-pediatric-monitor\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/owlet-announces-fda-510k-submission-for-prescription-pediatric-monitor\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Owlet Announces FDA 510(k) Submission for Prescription Pediatric Monitor"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49250","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49250"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49250\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49250"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49250"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49250"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}